Ethan Daniel Miller, MD

Peer-Reviewed Articles

1. Pritchard H, Hwang JP, Angelidakis G, Yibirin M, Wang L, Miller ED, Torres HA. Hepatitis B Virus Reactivation in Cancer Patients Receiving Direct-Acting Antivirals for Hepatitis C Virus Infection. J Viral Hepat 28(5):844-848, 2021. e-Pub 2021. PMID: 33523503.
2. Torres HA, Lok AS, Suarez-Almazor ME, Warneke CL, Kaseb A, Miller ED, Sturgis EM, Foreman JT, Angelidakis G, Ahmed S, Ferrajoli A, Samaniego F, Hawk ET, Hwang JP. Strategies to Identify Hepatitis C Virus Infection in Patients Receiving Anticancer Therapy: A Cross-Sectional Study. Support Care Cancer 29(1):05456-3, 2021. e-Pub 2020. PMID: 32314052.
3. Regev A, Avigan MI, Kiazand A, Vierling JM, Lewis JH, Omokaro SO, Di Bisceglie AM, Fontana RJ, Bonkovsky HL, Freston JW, Uetrecht JP, Miller ED, Pehlivanov ND, Haque SA, Harrison MJ, Kullak-Ublick GA, Li H, Patel NN, Patwardhan M, Price KD, Watkins PB, Chalasani NP. Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development. J Autoimmun 114, 2020. e-Pub 2020. PMID: 32768244.
4. Hill A, Elakkad A, Kuban J, Sabir S, Odisio B, Huang SY, Mahvash A, Miller ED, Kroll MH, Overman M, Tam AL, Gupta S, Sheth RA. Durability of partial splenic artery embolization on platelet counts for cancer patients with hypersplenism-related thrombocytopenia. Abdominal Radiology 45(9):2886-2894, 2020. e-Pub 2020. PMID: 32314004.
5. Sydney Pomenti S, Gandle C, Abu-Sbeih H, Phipps M, Livanos A, Guo A, Yeh J, Burney H, Liu H, Dakhoul L, Kettler C, Gawrieh S, DeLemos A, Scanga A, Chalasani N, Miller ED, Wattacheril J. HEP4-20-0085.R1 Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort. Hepatology Communications 4(11):1708-1716, 2020. PMID: 33163839.
6. Chalasani, NP, Gawrieh S, DeLemos AS, Miller ED, Scanga AE, Burney HN, Wattacheril J. Gender Matters: Characteristics of Hepatocellular Carcinoma in Women from a Large, Multicenter Study in the United States. Amer Journal Gastroenterology, 2020. PMID: 32453046.
7. DeLemos A, Patel M, Gawrieh S, Burney H, Dakhoul L, Miller ED, Scanga A, Kettler C, Liu H, Roche P, Wattacheril J, Chalasani N. Distinctive features and outcomes of hepatocellular carcinoma (HCC) in patients with alcohol-related liver disease. Clin Transl Gastroenterol 11(3), 2020. PMID: 32352723.
8. Miller ED, Abu-Sbeih H, Styskel B, Gonzalez GN, Blechacz B, Naing A, Chalasani N. Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors. American Journal of Gastroenterology 115(2):251-261, 2020. PMID: 31789632.
9. Miller ED, Abu-Sbeih H, Styskel B, Nogueras Gonzalez GM, Blechacz B, Naing A, Chalasani N. Clinical characteristics and adverse impact of hepatotoxicity due to immune checkpoint inhibitors. Am J Gastroenterol 115(2):251-261, 2020. PMID: 31789632.
10. Raju GS, Lum P, Abu-Sbeih H, Ross WA, Thirumurthi S, Miller ED, Lynch P, Lee J, Bhutani MS, Shafi M, Weston B, Rashid A, Wang Y, Chang GJ, Carlson R, Hagan K, Davila M, Stroehlein J. Cap-fitted endoscopic mucosal resection of =?20?mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate. Endosc Int Open 8(2):E115-E121, 2020. e-Pub 2020. PMID: 32010742.
11. Stephen B, Hajjar J. Overview of Basic Immunology and Clinical Application. Adv Exp Med Biol(1244):1-36, 2020. PMID: 32301008.
12. Gawrieh S, Dakhoul L, Miller E, Scanga A, DeLemos A, Kettler C, Burney H, Liu H, Abu-Sbeih H, Chalasani N, Wattacheril J. Characteristics Etiologies and Trends of Hepatocellular Carcinoma in Patients without Cirrhosis: A United States Multicenter Study. Alimentary Pharmacology & Therapeutics 50(7):809-821, 2019. e-Pub 2019. PMID: 31475372.
13. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani MS, Shafi MA, Weston B, Blechacz B, Chang GJ, Hagan K, Rashid A, Davila M, Stroehlein J. Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20mm colon polyps. Endosc Int Open 7(3):E361-E366, 2019. e-Pub 2019. PMID: 30834295.
14. Torres HA, Economides MP, Angelidakis G, Hosry J, Kyvernitakis A, Mahale P, Jiang Y, Miller E, Blechacz B, Naing A, Samaniego F, Kaseb A, Raad II, Granwehr BP. Sofosbuvir-based therapy in hepatitis C virus-infected cancer patients: A prospective observational study. Am J Gastroentrol 114(2):250-527, 2019. PMID: 30410039.
15. Hwang JP, Lok MJ, Fisch SB, Cantor AB, Lin HY, Foreman JT, Vierling JM, Torres HA, Granwehr BP, Miller ED, Eng C, Simon GR, Ahmed S, Ferrajoli A, Romaguera J, Suarez-Almazor ME. Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anti-Cancer Therapy: A Prospective Cohort Study. Journal of Clinical Oncology 36(10):959-967, 2018. e-Pub 2018. PMID: 06114061.
16. Torres HA, Roach LR, Mahale P, Economides MP, Blechacz B, Miller ED, Borchardt R, Rashid A, Oo TH, Shukla B, Farida M, Ericsson CD, Granwehr BP, Raad II. Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center. J Natl Compr Canc Netw 14(9):1185-8, 2016. PMID: 27587628.
17. Raju GS, Lum PJ, Ross WA, Thirumurthi S, Miller ED, Lynch PM, Lee JH, Bhutani MS, Shafi MA, Weston BR, Pande M, Bresalier RS, Rashid A, Mishra L, Davila MD, Stroehlein JR. Outcome of EMR as alternative to surgery in patients with complex colon polyps. Gastrointest Endosc 84(2):315-25, 2016. e-Pub 2016. PMID: 26859866.
18. Torres HA, Mahale P, Miller ED, Frenette C. Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: as case series. J Hepatocell Carcinoma(1):109-14, 2016. PMID: 27508180.
19. Raju GS, Lum P, Slack RS, Thirumurthi S, Lynch PM, Miller ED, Weston BR, Davila ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR. Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointest Endosc 82(3):512-9, 2015. PMID: 25910665.
20. Torres HA, Mahale P, Blechacz B, Miller ED, Kaseb A, Herlong HF, Fowler N, Jiang Y, Raad II, Kontoyiannis DP. Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Network 13(1):41-50, 2015. PMID: 25583768.
21. Torres HA, Kaseb A, Mahale P, Miller ED, Frenette C. Telaprevir-containing regimen for treatment of hepatitis C virus infection in patient with hepatocellular carcinoma waiting liver transplantation: a case series. Journal of Hepatocellular Carcinoma 1:109-114, 2014. PMID: 27508180.
22. Torres HA, Mahale P, Miller ED, Oo TH, Frenette C, Kaseb AO. Co-administration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma. World J Hepatol 5(6):332-5, 2013. PMID: 23805358.
23. Islam S, Miller ED, Patel N, De Petris G, Highsmith EW, Fleischer DE. The use of DNA fingerprinting to resolve conflicting results in patients with suspected gastrointestinal malignancy. J Clin Gastroenterol 47(3):239-41, 2013. PMID: 23391868.
24. Miller ED, Steidley DE, Arabia FA, Decker GA. Gastric erosion associated with left ventricular assist device: new technology, new complication. Gastrointest Endosc 70(1):181-3, 2009. e-Pub 2009. PMID: 19152894.
25. Kramer JR, Davila JA, Miller ED, Richardson P, Giordano TP, El-Serag HB. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther 27(3):274-82, 2008. e-Pub 2007. PMID: 17996017.
26. Wong WT, Myhr KL, Miller ED, Wong RO. Developmental changes in the neurotransmitter regulation of correlated spontaneous retinal activity. J Neurosci 20(1):351-60, 2000. PMID: 10627612.
27. Miller ED, Tran MN, Wong GK, Oakley DM, Wong RO. Morphological differentiation of bipolar cells in the ferret retina. Vis Neurosci 16(6):1133-44, 1999. PMID: 10614593.

Abstracts

1. Zhang HC, Wang LS, Wang Y, Miller ED. Budesonide as an Alternative Steroid Agent, in Combination with Adjunctive Agents, for the Treatment of Immune Checkpoint Inhibitor-Mediated Cholangiohepatitis: A Case Study. Am J Gastroenterol 116(P):S1139, 2021.
2. Zhang HC, Taggart M, Miller ED, Fossella F, Wang LS. Extrahepatic Biliary Sequelae in Immune Checkpoint Inhibitor-Mediated Cholangiohepatitis: Urgent Unmet Need for Early Effective Treatment. Am J Gastroenterol 116(P):S1139, 2021.
3. Zhang HC, Eyada M, Taggart M, Miller ED, Negrao M, Varghese S, Wang LS. Clinical Presentation, Treatment Strategies, and Chronic Sequelae of Immune Checkpoint Inhibitor-Mediated Cholangiopathy: A Case Study. Am J Gastroenterol 116(P):1140, 2021.
4. Zhang, HC, Eyada, M, Miller, ED, Wang, LS. Tocilizumab as an alternative treatment strategy for immunotherapy-mediated hepatobiliary toxicity: addressing an urgent unmet need, 2021.
5. Wang LS, Zhang HC, Miller ED. Moderate Dose Steroid Treatment for Immune Checkpoint Inhibitor-Mediated Hepatotoxicity. Gastroenterology 160(6):S790, 2021.
6. Eyada M, Taggart MW, Wang LS, Miller ED, Zhang HC. Diagnosis and characteristics of immune checkpoint inhibitor-mediated cholangiopathy: a case series, 2021.
7. Yibirin M, Pundhir P, Yepez-Guevara E, Granwehr BP, Kaseb A, Patel S, Naing A, Shah AY, Skoulidis F, Tawbi HA, Zhang HC, Wang L, Miller ED, Torres HA. Safety of Immune Checkpoint Inhibitors in Cancer Patients with Chronic Hepatitis C Infection: A Prospective Observational Study. Poster presented at The Liver Meeting 2020, 2020.
8. Regev A, Avigan MI, Kiazand A, Vierling JM, Lewis JH, Omokaro SO, DiBisceglie AM, Fontana RJ, Bonkovsky HL, Freston JW, Uetrecht JP, Miller ED, Pehlivannov ND, Haque SA, Harrision MJ, Kullak-Ublick GA, Li H, Patel NN, Patwardhan M, Price KD, Watkins PB, Chalasani NP. Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development. Autoinnun 114(102514), 2020. PMID: 32768244.
9. DeLemos A, Patel M, Gawrieh S, Burney H, Dakhoul L, Miller ED, Scanga A, Kettler C, Liu H, Roche P, Wattacheril J, Chalasani N. Distinctive features and outcomes of hepatocellular carcinoma (HCC) in patients with alcohol-related liver disease: A UNITED STATES MULTICENTER STUDY. The Liver Meeting 11(3):e00139, 2020. PMID: 32352723.
10. Ferson D, Hagan K, Miller E, Carlson R, Zavala M, Winter E, Rahlfs T. Emergency airway management with the LMA during upper endoscopy in a patient with difficult-to-manage airway. Poster presentation, WAMM World Airway Management Meeting, 2019.
11. Raghavendra A, Barcenas CH, Hwang H, Wang X, Eke C, Avirineni A, Abu-Sbein H, Garg N, Lum P, Miller E. Clinical significance of elevated liver enzymes after exposure to endocrine therapy in early-stage breast cancer patients. Poster presentation, Seventh State of the Cancer Survivorship Research Symposium, 2019.
12. Phipps M, Livanos A, Guo A, Pomenti S, Yeh J, Dakhoul L, Burney H, Kettler C, Liu H, Miller ED, Gawrieh S, DeLemos AS, Scanga A, Chalasani NP, Wattacheril J. Distinct characteristics of hepatocellular carcinoma in women: Results from a large, Multicenter study in the United State. Poster presentation, DDW, 2019.
13. Torres HA, Economides MP, Angelidakis G, Hosry J, Kyvernitakis A, Mahale P, Jiang Y, Miller E, Blechacz B, Naing A, Samaniego F, Kaseb A, Raad II, Granwehr BP. Sofosbuvir-based therapy in hepatitis C virus-infected cancer patients: A prospective observational study. Am J Gastroentrol 114(2):250-257, 2019. e-Pub 2018. PMID: 30410039.
14. Abu-Sbeih H, Styskel B, Blechacz B, Chalasani N, Miller ED. Clinically Significant Hepatotoxicity Due to Immune Checkpoint Inhibitors Is Rare but Leads to Treatment Discontinuation in a High Proportion. AASLD, The Liver Meeting, 2018.
15. Miller ED, Dakhoul L, Abu Sbeih H, Mao E, DeLemos A, Roche P, Scanga A, Vilar Gomez E, Gawrieh S, Chalasani N, Wattacheril J. Increasing trend for hepatocellular carcinoma (HCC) linked to nonalcoholic fatty liver disease (NAFLD) in the United States. EASL International Liver Conference - Paris, France, 2018.
16. DeLemos A, Dakhoul L, Miller ED, Wattacheril J, Scanga A, Roche P, Abu Sbeih H, Mao E, Gomez EV, Gawrieh S, Chalasani N. Nonalcoholic fatty liver disease is the most common Cause of hepatocellular carcinoma (HCC) in individuals without cirrhosis: A United States multicenter study. EASL International Liver Conference - Paris, France, 2018.
17. Torres HA, Lok AS, Suarez-Almazor ME, Warneke CL, Miller ED, Kaseb A, Sturgis E, Angelidakis G, Ahmed S, Ferrajoli A, Samaniego F, Hawk E, Hwang JP. Hepatitis C virus risk tool for patients with cancer. The 2018 ASCO Annual Meeting, 2018.
18. Zhang HC, Dedania BK, Miller ED. Adverse Hepatobiliary Effects of Pegaspargase: Diagnostic Features and Potential Treatment. World Congress of Gastroenterology at ACG Annual Meeting, 2017.
19. Dedania BK, Zhang HC, Miller ED. Everolimus-induced Hypertriglyceridemia Manifesting as Acute Pancreatitis. World Congress of Gastroenterology at ACG Annual Meeting, 2017.
20. Alshawa A, Fujii T, Abu Sbeih H, Blechacz B, Bilen AM, Hess KR, Suarez-Almazor ME, Hong DS, Tsimberidou A, Gong J, Stephen B, Subbiah V, Piha-Paul SA, Fu S, Mendoza T, Thirumurthi S, Meric-Bernstam F, Naing A, Miller ED. Hepatotoxicity in advanced cancer patients receiving immune-based cancer treatment. 2018 ASCO-SITC Clinical Immuno-Oncology Symposium, 2017.
21. DaVee T, Deep A, Khuwaja S, Thirumurthi S, Nogueras-Gonzalez GM, Lum PJ, Bhutani MS, Miller ED, Lee JH. Does prior abdominal surgery increase the incidence of adverse events following percutaneous endoscopic gastrostomy tube placement 152(5):S417, 2017.
22. Hwang JP, Lok AS, Fisch MJ, Cantor SB, Barbo AG, Lin HY, Foreman JT, Vierling JM, Torres H, Granwehn B, Miller ED, Saurez-Almazor M,. Predicting Hepatitis B Virus Infection among Patients with Cancer Undergoing Systemic Anti-cancer Therapy: A Prospective Cohort Study. 40th Annual Meeting of the Society of General Internal Medicine 32:S280, 2017.
23. Raju GS, Lum P, Ross W, Lynch PM, Thirumurthi S, Miller ED, Blechacz B, Weston BR, Shafi M, Bhutani MS. Better management of patients with large colon polyps requires improvement in the knowledge gaps among referring endoscopists. Presented at Digestive Disease Week, May 6-9,2017,Chicago,IL. Gastrointest Endosc 85(5):AB545-546, 2017.
24. Weston BR, Ross, WA, Lum P, Thirumurthi S, Miller ED, et al.. Adenoma Detection Rate (ADR) and Serrated Adenoma Detection Rate (SDR) During Screening Colonoscopy With and Without a Personal Cancer History (PCH) in a Tertiary Referral Cancer Center. Poster Presentation Fourth State of the Science Cancer Survivorship Research Symposium, 2016.
25. Raju GS, Lum P, Ross W, Lynch PM, Thirumurthi S, Miller ED, Blechacz B, Weston BR, Shafi M, Bhutani MS, Lee JH, Davila ML, Stroehlein JR. Better Management of Patients with Large Colon Polyps Requires Improvement in the Knowledge Gaps Among Referring Endoscopists. ASGE, 2016.
26. Raju GS, Lum P, Ross W, Lynch PM, Miller ED, Thirumurthi S, Blechacz B, Lee JH, Shafi M, Bhutani MS, Asif R, Weston BR, Davila ML, Stroehlein JR. Outcome of a Protocol Driven Endoscopic Resection of patients with large colon polyps (<20mm) results in low complications and recurrence. ASGE, 2016.
27. Torres HA, Mahale P, Granwehr B, Miller ED, Borchardt R, Shukla B, Ericsson CD, RaadII. Transdisciplinary approach to managing HCV infection in patients at a tertiary care center. Infectious Diseases Society of America Accepted for poster presentation at the 2015 ID Week, 10/7-11/2015, San Diego CA, 2015.
28. Patham B, Miller ED, Murphy WA, I-Nan Hu M. Tenofovir-Related Hypophosphatemic Ostemomalacia and Multiple Fractures Mimicking Metastatic Bone Disease in a Patient with Hepatocellular Carcinoma. Endocrine Society's 97th Annual Meeting and Expo San Diego, CA, 2015.
29. Weston BR, Ross WA, Lum P, Thirumurthi S, Miller ED, Bhutani MS, Blechacz B, Bresalier RS, Davila ML, Dekovich AA, Guha S, Lee JH, Lynch PM, Pande M, Asif R, Shafi MA, Shuttlesworth G, Stack RS, Mishra L, Stroehlein JR, Raju GS. Adenoma detection rate (ADR) and serrated adenoma detection rate (SDR) during screening colonoscopy with and without a personal cancer history (PCH) in a tertiary referral cancer center. Gastrointestinal Endoscopy-DDW Poster Presentation 79(5):AB202, 2014.
30. Phillip Lum, Ross WA, Pande M, Lynch PM, Miller ED, et al. Measures to Improve Colonoscopy Quality Metrics. Poster DDW 2014 Gastrointestinal Endoscopy 79(5S):Sa1409, 2014.
31. Thirumurthi S, Ross WA, Lum P, Miller ED, Weston BR, et al.. Adenoma Detection Rate & Sessile Serrated Adenoma Detection Rate Trends With Increasing Age: a Study Using a Natural Language Processing Computer Program. Poster DDW 2014. Gastrointestinal Endoscopy 79(5S):Sa1412, AB203, 2014.
32. Miller ED, Ross WA, Lum P, Thirumurthi S, Weston BR, Pande M, et al.. Screening Colonoscopy Quality Metrics for Males and Females Across Ethnic Groups Using a Natural Language Processing Algorithm. Poster DDW 2014. Gastrointestinal Endoscopy 79(5S):Sa1409, 2014.
33. Raju G, Ross WA, Lum P, Lynch PM, Slack RS, Miller ED et al.. Natural Language Processing (NLP) As an Alternative to Manual Reporting of Colonoscopy Quality Metrics. Oral Presentation DDW 2014. Gastrointestinal Endoscopy 79(5S, 166,):AB116-AB117, 2014.
34. Miller ED, Blechacz B, Herlong HF, Davila M, Torres HA. The effect of antiviral therapy on progression of liver disease in Hepatitis C Virus-infected patients with malignancies. The Liver Meeting AASLD's 64th Annual Meeting in Washington, DC, November 1 - November 5, 2013, 2013.
35. Torres HA, Davila M, Mulanovich VE, Granwehr BP, Miller ED, Nevah MI, Mishra L, Kontoyiannis DP. Hepatitis C Clinic at a Comprehensive Cancer Center: The successful story of multidisciplinary efforts. Infectious Diseases Society of America Accepted for poster presentation at the 49th IDSA Annual Meeting, 10/20-23/2011, Boston MA, 2011.
36. Miller ED, Steidley D, Arabia F, Das A, Crowell M, Leighton J, Decker A.. Gastrointestinal complications associated with left ventricular assist devices. Am J Gastroenterol 103(Suppl S):S521-2, 2008. PMID: 20845267.
37. Miller ED, Hampel H, Goodgame RW.. A novel mutation involving an insertion in exon 4 of the APC gene leading to an uncommon phenotype: A 62 year-old man with synchronous colon cancers and 175 adenomas. Am J Gastroenterol 99(10):S350, 2004.
38. Miller ED, Wong GK, Oakley DM, Wong ROL.. Morphological and functional development of bipolar cells in the ferret retina. Soc for Neurosci 23:641, 1997.
39. Miller ED. Five-Year Trends in Adenoma Detection Rates: A Report From A Single Academic Group Practice.

Book Chapters

1. Zhang HC, Wang LS, Miller E. Hepatobiliary and Pancreatic Adverse Events. In: Advance in Experimental Medicine and Biology. Springer, 339-355, 2021.
2. Miller ED, Abu-Sbeih H, Chalasani NP. Drug-Induced Liver Injury in Older Adults in Geriatric Gastroenterology. In: Geriatric Gastroenterology. Springer: Switzerland, 1-16, 2020.
3. Miller ED, Harrison MEH.. Gallstones, Gallbladder Polyps and Their Complications: Epidemiology, Pathogenesis, Diagnosis, and Management. In: Practical Gastroenterology and Hepatology. Oxford Blackwell: United States, 2010.
4. Wong ROL, Miller ED, Wong WT, Shields CR, Cyhr KL.. Development changes in the spontaneous bursting patterns of on and off ganglion cells. In: Development and Organization of the Retina: From Molecules to Function. Plenum Press: New York, 275-88, 1998.